Pharma Trend: Companies are Waiving Drug Patents in Developing Countries
Elementum
MAY 23, 2016
In response to criticisms that many new drugs are too expensive for many people in Asia, Africa, and Latin America, pharmaceutical giant GlaxoSmithKline (GSK) announced on Thursday, March 31, that it will not be filing patents for its products in the world’s poorest countries, while continuously seeking patent protection in rich countries.
Let's personalize your content